Clinical trial
Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER): a Multicenter, Observational, 3-arms, Prospective Study
NCT07435467 is registered in ClinicalTrials.gov with Istituto Nazionale di Ricovero e Cura per Anziani as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER): a Multicenter, Observational, 3-arms, Prospective Study
- Lead sponsor
- Istituto Nazionale di Ricovero e Cura per Anziani
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 9, 2025
- Completion date
- June 30, 2026
- Enrollment
- 400 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, old age; dementia